Skip to main content
Figure 3 | Parasites & Vectors

Figure 3

From: Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis

Figure 3

Forest plots showing the efficacy of AM using 6 mg/kg for preventing schistosome infection (RCTs). The trials were stratified into sub-groups based on dosages and Schistosoma species. (01) 4-7 doses by 15-day intervals for preventing S. japonicum infection (pooled RR was synthesized by the fixed-effect model); (02) 2-3 doses by 15-day intervals for preventing S. japonicum infection of short term exposure; (03) 8-13 doses by 15-day intervals for preventing S. japonicum infection (pooled RR was synthesized by random-effect model); (04) 6-7 doses by 3-week intervals for preventing S. mansoni infection; (05) 6-7 doses by 1-month intervals for preventing schistosome infection - S. haematobium and S. japonicum (pooled RR was synthesized by the fixed-effect model).

Back to article page